Innovative Drug Stocks Rally Against Market Trend, Harbin Sanlian Hits 3 Limit-Up Boards in 4 Days
Innovative drug stocks rallied against the broader market's weakness, with Harbin Sanlian hitting three limit-up boards in four days and Yibai Pharmaceutical achieving two limit-ups in four days. Other stocks including Longshen Rongfa, Ruizhi Pharmaceutical, Xin Ganjiang, and Joinn Laboratories also gained.
Innovative drug stocks bucked the weaker market trend and rallied. Harbin Sanlian recorded three daily limit-up moves in four trading sessions, and Yibai Pharmaceutical posted two limit-ups in four days. Longshen Rongfa, Ruizhi Pharmaceutical, Xin Ganjiang, and Joinn Laboratories also rose in sympathy.